These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 8837321
1. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Thyroid; 1996 Jun; 6(3):161-8. PubMed ID: 8837321 [Abstract] [Full Text] [Related]
2. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P. Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322 [Abstract] [Full Text] [Related]
5. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y. J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447 [Abstract] [Full Text] [Related]
6. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. Pantazi H, Papapetrou PD. J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046 [Abstract] [Full Text] [Related]
9. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C. Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627 [Abstract] [Full Text] [Related]
10. Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. Olkawa M, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Ogihara H, Ishigaki J, Inoue T. Clin Endocrinol (Oxf); 1999 Feb; 50(2):171-6. PubMed ID: 10396358 [Abstract] [Full Text] [Related]
11. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. Hansen TB, Brixen K, Vahl N, Jørgensen JO, Christiansen JS, Mosekilde L, Hagen C. J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096 [Abstract] [Full Text] [Related]
13. Circulating telopeptide type I is a peripheral marker of thyroid hormone action in hyperthyroidism and during levothyroxine suppressive therapy. Loviselli A, Mastinu R, Rizzolo E, Massa GM, Velluzzi F, Sammartano L, Mela Q, Mariotti S. Thyroid; 1997 Aug; 7(4):561-6. PubMed ID: 9292943 [Abstract] [Full Text] [Related]
15. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. Boot AM, De Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL. J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543 [Abstract] [Full Text] [Related]
16. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: effects on bone metabolism amongst premenopausal women. Knudsen N, Faber J, Sierbaek-Nielsen A, Vadstrup S, Sørensen HA, Hegedüs L. J Intern Med; 1998 Feb; 243(2):149-54. PubMed ID: 9566644 [Abstract] [Full Text] [Related]
17. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency. de Boer H, Blok GJ, Popp-Snijders C, Sips A, Lips P, van der Veen E. J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517 [Abstract] [Full Text] [Related]
19. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women. Zofkova I, Hill M. Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899 [Abstract] [Full Text] [Related]